CVRx, Inc. (CVRX)
NASDAQ: CVRX · IEX Real-Time Price · USD
14.90
-0.36 (-2.36%)
At close: Apr 19, 2024, 4:00 PM
14.55
-0.35 (-2.35%)
After-hours: Apr 19, 2024, 5:34 PM EDT
CVRx, Inc. Market Cap
CVRx, Inc. has a market cap or net worth of $311.82 million as of April 19, 2024. Its market cap has increased by 65.95% in one year.
Market Cap
311.82M
Enterprise Value
251.64M
1-Year Change
65.95%
Ranking
Category
Stock Price
$14.90
Market Cap Chart
Since the IPO on June 30, 2021, CVRx, Inc.'s market cap has decreased from $347.31M to $311.82M, a decrease of -10.22%. That is a compound annual growth rate of -3.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 319.40M | -2.86% |
Apr 17, 2024 | 328.80M | -4.08% |
Apr 16, 2024 | 342.80M | -1.49% |
Apr 15, 2024 | 348.00M | -3.49% |
Apr 12, 2024 | 360.60M | -4.75% |
Apr 11, 2024 | 378.60M | 0.66% |
Apr 10, 2024 | 376.10M | -6.40% |
Apr 9, 2024 | 401.80M | 3.16% |
Apr 8, 2024 | 389.50M | 5.27% |
Apr 5, 2024 | 370.00M | 1.70% |
Apr 4, 2024 | 363.80M | 0.78% |
Apr 3, 2024 | 361.00M | 0.28% |
Apr 2, 2024 | 360.00M | -4.28% |
Apr 1, 2024 | 376.10M | -1.31% |
Mar 28, 2024 | 381.10M | 1.22% |
Mar 27, 2024 | 376.50M | -0.26% |
Mar 26, 2024 | 377.50M | -2.08% |
Mar 25, 2024 | 385.50M | -7.80% |
Mar 22, 2024 | 418.10M | -6.51% |
Mar 21, 2024 | 447.20M | 2.29% |
Mar 20, 2024 | 437.20M | 1.06% |
Mar 19, 2024 | 432.60M | 0.09% |
Mar 18, 2024 | 432.20M | -0.80% |
Mar 15, 2024 | 435.70M | -3.11% |
Mar 14, 2024 | 449.70M | -1.75% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tenaya Therapeutics | 337.62M |
Tactile Systems Technology | 336.43M |
MeiraGTx Holdings | 333.89M |
Health Catalyst | 329.42M |
Anavex Life Sciences | 329.01M |
Atai Life Sciences | 328.73M |
Precigen | 326.08M |
Lyra Therapeutics | 322.91M |